• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

The Weekly Roundup: August 26-30

In case you missed it, this week we had news about the AHEAD atopic dermatitis treatment recommendations, positive long-term results for roflumilast cream 0.05% in pediatric patients, line-field optical coherence tomography for dermal fillers, and more.

Dermatology Times Weekly Roundup

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Patients With Psoriasis Demonstrate Higher Rates of Helicobacter Pylori Infection Versus Controls

Rates of infection did not correlate with disease severity, however.

Experts Report Moderate Patient Adherence to Melanoma Screening and Surveillance Program

Researchers tailored screening and surveillance schedules to individual risk of patients.

Concentrated Growth Factors Show Promise for Treating AGA

A recent study found after 6 months, CGF therapy resulted in a sustained increase in terminal hair density without significant adverse events.

Vitiligo Care Personalized for Each Patient: Part 4

At the conclusion of their roundtable event, Rocco Serrao, MD, FAAD; Latanya Benjamin, MD, FAAD; and Anthony Nuara, MD, PhD, discuss final considerations for tailoring vitiligo treatment plans.

A Paradox of Anti-Inflammatory Biologics

Biologics work by inhibiting inflammatory cytokines, but a small percentage of patients may experience “paradoxical psoriasis.”

DPCP Immunotherapy Yields 61.8% Hair Regrowth Rate in Pediatric Alopecia Areata

Approximately 8.8% of patients achieved complete response a year after onset of diphenylcyclopropenone therapy.

Case of Juvenile Bullous Pemphigoid with Negative Serum BP180 ELISA Test Reveals Need for Additional Testing

Bullous pemphigoid in youth is rare and can be missed due to negative BP180 ELISA results, complicating timely diagnosis in children.

Facial Botox Injections May Elevate Mood, Study Finds

The findings support the idea that Botox can enhance emotional well-being and self-confidence, although it did not notably impact the quality of life.

Action Plan Reduces AD Severity and Enhances QoL in Adultsc

The study found that after 4 weeks of using the action plan, AD severity decreased markedly, with many patients achieving mild AD status.

New Treatment Targets for Atopic Dermatitis

The AHEAD recommendations focus on achieving disease control in atopic dermatitis by allowing patients to identify key symptoms and clinicians to select matching outcomes to guide therapy, aiming for a higher standard of care.

Differences in Efficacy of Platelet-Rich Plasma With Versus Without Photoactivation Minimal, According to Study in Melasma

Researchers say further studies are needed to understand the effects of photoactivation, if any, in combination with PRP.

Positive Long-Term Results for Roflumilast Cream in Young Children

Results from the study highlight that the therapy improves AD symptoms over time, with 71.9% of participants achieving substantial improvement.

Overcoming Therapeutic Inertia in Atopic Dermatitis—The AHEAD Recommendations as a Path Forward

By setting higher treatment goals, the AHEAD recommendations emphasize the importance of achieving optimal targets for both skin clearance and itch relief in atopic dermatitis.

The Role of AI in Enhancing Cosmetic Dermatology Practices

A recent review highlighted how AI can be used to enhance diagnostic accuracy, consultations, treatment planning, and patient education.

Patients Report Higher Treatment Satisfaction With Surgery Versus Other Actinic Keratosis Therapies

One hundred patients with AK rated their therapies with the TSQM and Likert scale, and shared their treatment needs regarding goals, cost, type, duration, and location.

Discovering Dermatology Times: August 2024 Personalized Vitiligo Care Supplement

Learn more about the in-depth topics covered in the August 2024 supplement of Dermatology Times.

Discovering Dermatology Times: August 2024 Print

Learn more about the in-depth topics covered in the August 2024 print issue of Dermatology Times.

LC-OCT Demonstrates Non-Invasive Evaluation Capabilities of Dermal Fillers

At T0, skin layers appeared normal, and at T1, filler deposits were clearly visible as hyporeflective areas.

Hyaluronic Acid Compound Demonstrates Effective Improvement of Keratosis Pilaris

Researchers observed significant improvements in roughness and redness in patients treated with the non-cross-linked compound.

Chronic Hand Eczema and the Impact of Corticosteroid Fear

Chronic hand eczema patients with high corticosteroid phobia are less likely to follow prescribed treatments, indicating a need for improved education.

Exploring Genetic Factors in Vitiligo and AA

Researchers identified KLB and EIF3C as potential biomarkers for vitiligo and AA, offering new targets for early diagnosis and treatment.

Interview Intersection: Expert Interviews From August 2024

Dermatology Times is recapping our top expert interviews from the month of August.

Dermatology Times August 2024 Recap

Dermatology Times is looking back on the top stories in dermatology from the month of August.

PRP Therapy Shows Promise for Female Hair Loss

Recent studies found that PRP therapy leads to noticeable decreases in hair shedding and increases in hair thickness.

Highlights From Psoriasis Awareness Month

Throughout the month of August, Dermatology Times covered psoriasis news related to Alumis Inc’s phase 3 trial of ESK-001 for plaque psoriasis, AbbVie’s Science of Skin event, and more.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.